❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Immunology ❭ Molecular immunology and vaccine development (Braathen) ❭ In the media ❭

In the media

Blog: Vaksinebloggen

Podcast: Vaksinepodden

 
Scroll to top

Home Dept. of Immunology Molecular immunology and vaccine development (Braathen)

  • Group members
  • Publications
  • In the media
  • Funding

Recent publications

Rohringer A, Ebbesen MH, Fossum E, Nygaard RM, Madsen BB, Storm M, Aasand N, Rydland K, Bragstad K, Hungnes O (2026)
A series of diagnostic contamination events from seasonal influenza vaccines
J Clin Virol, 182, 105912 (in press)
DOI 10.1016/j.jcv.2026.105912, PubMed 41529325

de Jong R, Zhou F, Andersen TK, Stockhofe-Zurwieden N, Cox RJ, Bogen B, Grodeland G (2025)
An HLAII-targeted DNA vaccine against influenza H7N9 protected mice and ferrets from a virus challenge
NPJ Vaccines (in press)
DOI 10.1038/s41541-025-01341-4, PubMed 41444253

Tunheim G, Baranowska-Hustad M, Lund-Johansen F, Fossum E, Bhandari S, Kukule L, Møller TKR, Vikse EL, Bekkevold T, Oftung F, Robertson AH, Næss LM (2025)
SARS-CoV-2 Infection With Alpha B.1.1.7 Virus Induced Higher Antibody Responses Than Earlier Non-VOC Variants During the First Waves of the COVID-19 Pandemic in Norway
APMIS, 133 (12), e70102
DOI 10.1111/apm.70102, PubMed 41376258

More publications

Get in touch

Ranveig Braathen
Institute of Immunology, Rikshospitalet, Oslo University Hospital
Sognsvannsveien 20, Section A2. 2nd. floor, Room:  A3.2006, 0372 Oslo, Norway
Phone: + 47 23 07 35 08, Cell: + 47 99732296, Fax: + 47 23 07 35 10
Email: Ranveig.braathen@medisin.uio.no, Ranveig.braathen@rr-research.no, ranvbr@ous-hf.no

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)